General Information
CONFERENCE INFORMATION
The Adherence 2023 conference will take place in June 11-13, 2023, at El Conquistador in Puerto Rico. Provided by the International Association of Providers of AIDS Care (IAPAC), in joint partnership with Albert Einstein College of Medicine-Montefiore Medical Center (Einstein-Montefiore), this annual series of conferences features the presentation and discussion of HIV treatment and biomedical prevention adherence research, and current behavioral and clinical perspectives in practicum, within the context of optimizing the continuum of HIV care and prevention.
Under the theme of Advancing Equity and Innovation for Impact, the conference will feature a Keynote Address, Memorial Lecture, Memorial Colloquium, four thematic sessions, oral abstracts sessions (including late-breakers), and an e-poster abstracts session. The conference will include four tracks:
- HIV Care Continuum
- Implementation Science
- Optimizing ART Adherence
- PrEP Uptake, Adherence, and Persistence
The Adherence 2023 conference Co-Chairs are Jane M. Simoni (University of Washington, Seattle, WA) and Carmen Zorrilla (University of Puerto Rico, San Juan, PR).
The most up-to-date conference program is viewable by clicking “Schedule” above. A downloadable PDF version of the program may be accessed by clicking here.
OBJECTIVES
Upon successful completion of this activity, learners will be able to:
1. Employ interventions to enhance linkage to and retention in and sustained engagement in HIV care
2. Apply strategies to optimize antiretroviral therapy and pre-exposure prophylaxis adherence
3. Utilize implementation science to inform evidence-based approaches to implement optimized HIV responses
4. Integrate community participatory engagement into clinical practice to support patient-focused care environments
TARGET AUDIENCE
The target audience for the Adherence 2023 conference includes physicians, nurses and nurse-practitioners, pharmacists, psychologists, behavioral scientists, social scientists, public health specialists, epidemiologists, social workers, case managers, peer educators and navigators, and community health workers working in the field of HIV medicine. Because the conference outcomes are intended to influence public policy around global, national, and municipal HIV responses, the conference may also be of interest to policymakers and individuals who wish to advocate as well as enact and implement evidence-informed HIV policies and interventions in their respective communities and countries.
ACCREDITATION
ACCREDITATION STATEMENT
 |
In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and the International Association of Providers of AIDS Care. Albert Einstein College of Medicine-Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. |
 |
This activity was planned by and for the healthcare team, and learners will receive 16.25 Interprofessional Continuing Education (IPCE) credits* for learning and change.
*For physicians, this is the number of AMA PRA Category 1 CreditTM awarded. *For non-physicians, this is the number of AMA PRA Category 1 CreditTM designated. |
CREDIT DESIGNATION STATEMENTS
Physicians
Albert Einstein College of Medicine-Montefiore Medical Center designates this live activity for a maximum of 16.25 AMA PRA Category 1 CreditTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Nurses
Albert Einstein College of Medicine-Montefiore Medical Center designates this activity for 16.25 nursing contact hours. Nurses should claim only credit commensurate with the extent of their participation in the activity.
Pharmacists
|
|
Albert Einstein College of Medicine-Montefiore Medical Center designates this continuing education activity for 16.25 contact hours (1.625 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number – Pharmacists: JA4008224-9999-22-044-L02-P, Pharmacist Technicians: JA4008224-9999-23-006-L02-T.
Type of Activity: Knowledge-based After completion of the activity and submission of the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days. |
FACULTY DISCLOSURE STATEMENT
The “Policy on Identification, Mitigation and Disclosure of Relevant Financial Relationships” of Albert Einstein College of Medicine- Montefiore Medical Center requires that any individual in control of content, including faculty, participating in CME/CE activities disclose to the audience all relevant financial relationships with ineligible companies* in the last 24 months. Any individual in control of content who refuses to disclose, or their disclosed relationships prove to create a conflict of interest will be recused. Individuals with the absence of relevant financial relationships with ineligible companies will be disclosed to the audience. All financial relationships of individual(s) in a position to control the content of this CME/CE activity has been identified and mitigated prior to this educational activity.
* The ACCME defines an ineligible company as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
REGISTRATION
Following are key dates for early and standard conference registration, as well as registration rates:
Early Registration Deadline – February 10, 2023Standard Registration Deadline – May 12, 2023Registration Cancellation Deadline (with $100 penalty) – May 12, 2023
| Deadline | N/A | ||
| Registration Type | Standard | Late/Onsite | |
| Member (must be current) | $325 | ||
| Non-Member | $350 | ||
| Student or Retired | $225 | ||
| One-Day Only | $200 |
ABSTRACT SUBMISSION
Following are key dates for abstract submission (with additional information and guidance available by clicking the Abstracts tab on this webpage):
Abstract Submission/Disposition
Abstract Submission Deadline – March 3, 2023Late-Breaker Abstract Submissions – March 27-31, 2023Abstract Disposition Announcements – April 7, 2023Late-Breaker Disposition Announcements – April 21, 2023Deadline to Withdraw Abstract/Change Presenting Author – May 5, 2023
HOTEL ACCOMMODATIONS
IAPAC has negotiated a discounted room block for conference attendees. Following is a key date for making hotel room reservations within the discounted room block:
Hotel Accommodations
Discounted Room Block Reservation Deadline – May 11, 2023(SOLD OUT)
Select the “Venue” tab above to access the room reservation link.
EXHIBITOR AND SPONSORSHIP INFORMATION
The Adherence 2023 conference provides an opportunity to interact with more than 400 delegates in-person from a variety of practice settings and experiences, including physicians, nurses, pharmacists, psychologists, social workers, community health workers, and patient advocates. There are a limited number of sponsorship opportunities available for this conference. Please contact IAPAC’s Senior Director of Education Jonathon Hess at jhess@iapac.org with any sponsorship-related queries. View the Adherence 2023 Exhibitor and Sponsorship Prospectus.
ACKNOWLEDGEMENT
The Adherence 2023 conference is made possible through an educational grant from Merck & Co., corporate sponsorships from Gilead Sciences and ViiV Healthcare, and individual registration and exhibitor fees.
Schedule
SUNDAY, JUNE 11, 2023
| TIME | SESSION | ROOM |
|---|---|---|
| 10:30 AM - Noon | PRE-CONFERENCE SESSION
Achieving Equitable HIV Outcomes Moderators: Cecilia Chung, Transgender Law Center, Oakland, CA, USA Corey Prachniak-Rincón, CenterLink, Boston, MA, USA Panelists: Mandy Hill, UTHealth Houston, Houston, TX, USA Arianna Lint, Arianna’s Center, Fort Lauderdale, FL, USA Carlos Rodriguez-Diaz, George Washington University, Washington, DC, USA | General Session
Grand Caribbean Salon 4 |
| Communities at the Center: Achieving Equitable HIV Outcomes
Moderators: Cecilia Chung (Transgender Law Center, Oakland, CA, USA) Corey Prachniak-Rincón (CenterLink, Boston, MA, USA) | ||
| 1:00 PM - 1:15 PM | WELCOME REMARKS | General Session
Grand Caribbean Salon 4 |
| Welcome to Adherence 2023
Jane M. Simoni (University of Washington, Seattle, WA, USA) Carmen Zorrilla (University of Puerto Rico, San Juan, PR) José M. Zuniga (IAPAC, Tampa, FL, USA) | ||
| 1:15 PM - 1:45 PM | KEYNOTE ADDRESS Beyond the Rhetoric: Implementing Solutions to Health Inequities Antonia C. Novello (14th US Surgeon General, Orlando, FL, USA) | General Session
Grand Caribbean Salon 4 |
| 1:50 PM - 3:05 PM | HIV CARE CONTINUUM
Moderator: Aadia Rana (University of Alabama at Birmingham, Birmingham, AL, USA) | General Session
Grand Caribbean Salon 4 |
| Cutting Edge Services: Clinical Implementation of Long-Acting ART
Iván Meléndez-Rivera (Centro Ararat, San Juan, PR) | ||
| Impact Innovation: Utilizing mHealth Interventions to Advance Equity in the Care Continuum
Karen Ingersoll (UVA Health, Charlottesville, VA, USA) | ||
| Equitable Health Literacy Interventions: Promoting Adherence to HIV Treatment and Care
Tamara Taggart (George Washington University, Washington, DC, USA) | ||
| 3:05 PM - 3:15 PM | Break | |
| 3:15 PM - 4:15 PM | ORAL ABSTRACTS SESSIONS 1 | |
| Adherence and Retention in HIV Care: Understanding and Addressing Challenges
Moderator: TBC 1015 Factors Associated with ART Adherence for Prevention and Treatment Among Sexual Minority Men: Integrating Traditional and Machine Learning Approaches Presenter: Audrey Harkness 1166 Fidelity of Multi-month ARV Dispensing and Viral Load Outcomes: Results from a Cohort Study in Cote d’Ivoire Presenter: Lauren Greenberg 1225 PWID Living with HIV in India Experience Viral Rebound on ART and Persistent Viremia Presenter: Talia Loeb 1253 Men Interrupted: High Rates of Treatment Interruptions among Men who have Sex with Men (MSM) Necessitate Tailored Approaches Presenter: Dorian Gule 1259 Limited Receipt of Annual Routine Preventive Care Services among Medicaid Enrollees Living with HIV in the US South Presenter: Jessica Kiernan | Breakout 1
Grand Caribbean S1-3 | |
| HIV Treatment Continuity and Retention in Care Moderator: TBC 1063 Re-Linkage Protocol for Out of Care HIV Patients at an Urban Emergency Department Presenter: Heather Henderson 1226 Community Solutions for Promoting Treatment Continuity and Re-Engaging Children and Adolescents Living with HIV (C/ALHIV) in HIV Treatment and Care in Uganda Presenter: Emmanuel Tibenderana 1235 Scaling up Rapid Linkage to HIV Treatment in Los Angeles County Using a Learning Collaborative Approach Presenter: Elise Berrier 1239 Fostering Engagement in Care and Medication Adherence through a Systematic Quality Improvement Initiative for Continued Enrollment in the AIDS Drug Assistance Program Presenter: Kellie Hawkins 1298 Treatment Continuity: The Cornerstone of HIV Epidemic Control in Resource Constrained Settings Presenter: Yussif Ahmed Abdul Rahman | Breakout 2
Grand Caribbean S6-8 | |
| PrEP Uptake and Adherence Moderator: TBC 1041 Eligibility for PrEP Referral, Referral to PrEP Provider, and Assistance with Linkage to PrEP Provider among Persons Testing Negative for HIV Infection via CDC-Funded HIV Testing in Non-Healthcare Settings Presenter: Deesha Patel 1086 Preference for Long-Acting Pre-Exposure Prophylaxis (PrEP) by Adherence and Persistence on Daily Oral PrEP among Cisgender Women and Black and Hispanic Men in the United States Presenter: Carolyn Brown 1093 Preferences Regarding a Real-time Urine Assay for Monitoring and Providing Feedback on Pre-Exposure Prophylaxis Adherence among Women in Kenya. Presenter: Phelix Okello 1100 Pharmacologic Drug Detection and Self-reported Adherence in the HPTN069/ACTG5305 Phase II PrEP Trial Presenter: Stanley Cooper 1129 Qualitative Analysis of a Warm Handoff Linkage Approach for Cisgender Black Women to Pre-exposure Prophylaxis (PrEP): A Systems Focus Presenter: Mandy Hill 1171 Vuka+, Novel Smartphone-based PrEP Adherence Support Intervention for Adolescent Girls and Young Women, Pilot Study Presenter: Homaira Hanif | Breakout 3
Grand Caribbean Salon 5 | |
| 4:15 PM - 4:25 PM | Break | |
| 4:25 PM - 5:30 PM | THREE TOP-RATED ABSTRACTS | General Session
Grand Caribbean Salon 4 |
| 6:00 PM - 8:00 PM | OPENING RECEPTION | Trellises |
| Awards Announcement |
MONDAY, JUNE 12, 2023
| TIME | SESSION | ROOM |
|---|---|---|
| 9:00 AM - 9:30 AM | ANDREW KAPLAN AND GARY S. REITER MEMORIAL LECTURE
HIV Stigma: Researching Innovations for Behavioral and Social Change Dianne Rausch (National Institute of Mental Health, Bethesda, MD, USA) | General Session
Grand Caribbean Salon 4 |
| 9:35 AM - 10:50 AM | OPTIMIZING ART ADHERENCE
Moderator: Andrew Mujugira (Makerere University, Kampala, Uganda) | General Session
Grand Caribbean Salon 4 |
| Long-Acting Options: Lessons Learned from Prevention to Inform Treatment
Ariane van der Straten (HIV Prevention Trials Network, San Francisco, CA, USA) | ||
| Optimizing ART Adherence to Reach the Third 95
Juliana de Oliveira Costa (University of New South Wales, Sydney, NSW, Australia) | ||
| Point-of-Care Technologies for Supporting HIV Treatment Adherence
Monica Gandhi (UCSF Center for AIDS Research, San Francisco, CA, USA) | ||
| 10:50 AM - 11:05 AM | Break | |
| 11:05 AM - 12:15 PM | ORAL ABSTRACTS SESSIONS 2 | |
| Implementation Strategies and Adherence Support Moderator: TBC 1069 Mechanisms of Successful Implementation of Tailored Motivational Interviewing in a Multi-site Study of Youth HIV Clinics in the United States Presenter: Sylvie Naar 1101 Exploring Longitudinal Engagement in PrEP Care in a Cohort of Individuals Newly Initiating PrEP in St. Louis, Missouri from 2015-2021: A Multi-state Analysis Presenter: Lindsey Filiatreau 1113 How Ready are Ryan White Clinics to Implement Long-acting Injectable Antiretrovirals? Findings from a National Cross-sectional Survey Presenter: Adati Tarfa 1224 Beyond the Clinic: Improving Adherence and Viral Load Suppression for Children and Adolescents Living with HIV (C/ALHIV) in Uganda through Home-based Root Cause Analysis and Joint Action Planning Presenter: Baker Sserwambala 1236 HIV Implementation Literature Review Dashboard: Disseminating HIV Implementation Science Presenter: Artur Queiroz 1265 Health Department Based Intensive Case Management for Pregnant People Living with HIV as a Key Strategy to End the HIV Epidemic in Los Angeles County Presenter: Michael Haymer | Breakout 1
Grand Caribbean S1-3 | |
| Implementation Strategies for HIV Treatment and Prevention Moderator: TBC 1058 Implementation of Injectable Cabotegravir-Rilpivirine in an Ambulatory Infectious Diseases Clinic Presenter: Taylor Ward 1120 Preparing for Pharmacy-based Delivery of Long-Acting Injectable Antiretroviral Therapy Presenter: Jennifer Cocohoba 1201 Long-Acting Injectable ARV to Advance Health Equity: US Clinic Perspectives on Barriers, Needed Support, and Program Goals for Implementation Presenter: Nadia Nguyen 1205 Developing Implementation Strategies to Enhance PrEP Delivery to Immigrant Latino Men who have Sex with Men Presenter: Elena Rosenberg-Carlson 1245 Implementation Strategies and Determinants among Prevention-Focused Ending the HIV Epidemic Projects Presenter: Morgan Purrier 1263 Primary Care Providers’ Perceived Implementation Barriers for Biomedical HIV Prevention Strategies in Puerto Rico Presenter: Carlos Rodríguez-Díaz | Breakout 2
Grand Caribbean S6-8 | |
| Stigma and Mental Health Moderator: TBC 1031 Loneliness Among Black/African American Adults Living with HIV: Sociodemographic and Psychosocial Correlates and Implications for Adherence Presenter: Nipher Malika 1140 A Longitudinal Examination of Intersectional Stigma, Antiretroviral Therapy Adherence, and Viral Load Presenter: Kristi Stringer 1182 Tujuane Tujiamini: Community Perspectives of Stigma and Recommendations from People Living with HIV in Obunga, Kenya Presenter: Lauren Harrison 1218 Barriers to Mental Health Care, Anxiety and Depression, and HIV Care Engagement among People with HIV in Rural Florida Presenter: Preeti Manavalan Perceived Barriers and Facilitators to Informing People Living with HIV about Undetectable Equals Untransmittable: A Qualitative Study from the Perspective of Chinese Healthcare Providers Presenter: Qidi Zhou Community-Based Organisation’s Led Evaluation in HIV and Key Population Stigma- reduction Interventions in Gauteng Presenter: Tshepo Ndlovu | Breakout 3
Grand Caribbean Salon 5 | |
| 12:15 PM - 12:30 PM | Break | |
| 12:30 PM - 1:45 PM | SPONSORED LUNCH SYMPOSIUM
It Starts with a Conversation: An In-Depth Review of New Clinical Data and Patient Preference for a Long-Acting HIV Treatment Sponsored by ViiV Healthcare Presenters: Beata Casanas (USF Health, Tampa, FL, USA) Mark Lewandowski (ViiV Healthcare, Raleigh, NC, USA) | General Session
Grand Caribbean Salon 4 |
| 1:45 PM - 2:00 PM | Break | |
| 2:00 PM - 3:00 PM | E-POSTER ABSTRACTS SESSION | e-Poster Abstracts Monitors
South Foyer |
| 3:00 PM - 4:00 PM | ORAL ABSTRACTS SESSIONS 3 | |
| Strategies to Optimize ART Adherence Moderator: TBC 1064 Differentiation of Equivocal Human Immunodeficiency Virus (HIV) Screening Results in the Emergency Department Utilizing Specific Clinical Characteristics: The Importance of Patient Risk Factors Tshepo Ndlovu 1118 Improved Adolescent-Caregiver Relationships and Self-efficacy among Adolescents and Young Adults Living with HIV through Use of an ART Adherence Monitor Julian Adong 1161 Usability and Acceptability of an mHealth Platform for People Living with HIV in Washington, DC Sylvia Caldwell 1183 A Lateral Flow Device to Detect Emtricitabine in Urine for PrEP and ART Adherence Monitoring Thomas Vanderford 1195 Adherence to Hepatitis B Antiviral Treatment among People Living with Hepatitis B in Senegal Adrià Ramírez Mena | Breakout 1
Grand Caribbean S1-3 | |
| Technology and Access to HIV Care: Challenges and New Approaches Moderator: TBC 1037 Prevalence and Risk Factors for Post-Acute Sequelae of COVID among People Living with HIV in Washington, DC Presenter: Shannon Barth 1076 Dynamic Association between Intra-patient Variability in ARV Plasma Concentration and HIV RNA Viral Suppression – Findings from a Longitudinal HIV Study with Ingestible Sensor Monitoring Presenter: Yan Wang 1199 A Pilot Randomized Control Trial of Striving Towards EmPowerment and Medication Adherence (STEP-AD) among Black Women Living with HIV in the US Presenter: Sannisha Dale 1223 Telehealth Perspectives, Barriers, and Facilitators among People with HIV in Rural Florida: Qualitative and Quantitative Findings Presenter: Anne Gracy 1237 Does Size Matter? A Randomized Controlled Trial to Assess the Impact of External Diameter on Adherence to 3 Different Intravaginal Rings among 24 US Couples Presenter: Irene Bruce | Breakout 2
Grand Caribbean S6-8 | |
| ABSTRACTS TOPIC TBA | Breakout 3
Grand Caribbean Salon 5 | |
| 4:00 PM - 4:15 PM | Break | |
| 4:15 PM - 5:30 PM | PrEP UPTAKE, ADHERENCE, AND PERSISTENCE
Moderator: Kiplagat Anthony (CASCO, Nairobi, Kenya) | General Session
Grand Caribbean Salon 4 |
| Service Optimization: Expanding PrEP Delivery through Telehealth and mHealth Services
Elzette Rousseau (Desmond Tutu Health Foundation, Cape Town, South Africa) | ||
| New Opportunities: Implementing Long-Acting PrEP in Clinical Practice
Kenneth H. Mayer (Fenway Health, Boston, MA, USA) | ||
| Data to Action: Leveraging Data to Enhance PrEP Uptake and Persistence
Rupa Patel (Washington University in St. Louis, St. Louis, MO, USA) | ||
| 5:30 PM | Adjourn |
TUESDAY, JUNE 13, 2023
| TIME | SESSION | ROOM |
|---|---|---|
| 9:00 AM - 9:45 AM | MARIO S. COOPER MEMORIAL COLLOQUIUM Truth to Power: Exercising our Voices to Achieve Health Equity | General Session
Grand Caribbean Salon 4 |
| Kamaria Laffrey (The Sero Project Winter Haven, FL, USA)
Rafael Torruella (Intercambios, Fajardo, PR) | ||
| 9:50 AM - 11:05 AM | IMPLEMENTATION SCIENCE
Moderator: Elvin Geng (Washington University in St. Louis, St. Louis, MO, USA) | General Session
Grand Caribbean Salon 4 |
| Long Acting Injectables - Learning As We Go: An Implementation Science Agenda
Katerina Christopoulos (University of California San Francisco, San Francisco, CA, USA) | ||
| Ethnography and Implementation Science: The Case of Traditional Healers for HIV Testing
Radhika Sundararajan (Weill Cornell Medicine, New York, NY, USA) | ||
| Equity in the HIV Response: Implementation Science as Resistance
Cory Bradley (Fast-Track Cities St. Louis, St. Louis, MO, USA) | ||
| 11:05 AM - 11:20 AM | Break | |
| 11:20 AM - 12:30 PM | ORAL ABSTRACTS SESSIONS 4 | |
| Innovative Approaches for HIV Prevention and Treatment Moderator: TBC 1053 Combining Community-based Chronic Disease Care with Economic Strengthening Opportunities for Adults Living with HIV: Clustered Randomized Trial Evidence from Presenter: Kenya Marta Wilson-Barthes 1085 Safe in the Safe Space: Harnessing the Reach of Female Sex Workers (FSW) through Social Networks for Integrated Prevention and Treatment services: The Case of Mwanjuni Health Post Presenter: Julius Chilongoshi 1102 Development of an Online Metaphor Story Intervention to Promote Condom Use among Men Who Have Sex with Men in China Presenter: Ci Zhang 1149 Early Childhood Stimulation Intervention for Mothers Living with HIV Reduces Mother to Child Transmission Rates at 6 Weeks, 12 Months and 24 Months Deliwe Msiska Peer-Delivered HIV Self-Testing, STI Self-Sampling and PrEP for Transgender Women in Uganda: A Randomized Trial Presenter: Andrew Mujugira 1280 Examining the Effects of an Urban Gardens and Peer Nutritional Counseling Intervention on Alcohol Consumption and Tobacco Use among PLHIV in the Dominican Republic Presenter: Alane Celeste-Villalvir | Breakout 1
Grand Caribbean S1-3 | |
| Optimizing Care for Key Populations Moderator: TBC 1066 Cultural-adaption of an Internet-based Cognitive Behavioral Intervention among Young Men who have Sex with Men in China Presenter: Mengyao Yi 1071 Willingness to Receive HIV Self-testing Kits from Recent Sexual Partners among Men in Dar es Salaam, Tanzania: Findings from the STEP Project Baseline Survey Presenter: Kelia Olughu 1098 Structural Syndemics and HIV Care Among Justice Involved South Floridians Living with HIV Presenter: Felicia O. Casanova 1198 Sexual and Reproductive Health Needs Assessment of Adolescents and Young People Living With HIV (AYPLHIV) in Lagos State Presenter: Helen Omowumi Olowofeso 1200 Baylor College of Medicine ECHO Facilitating Antiretroviral StART Earlier (BE FASTER) Community of Practice for Increasing Rapid ART in Houston: A Qualitative, Longitudinal Study Presenter: Shital Patel 1256 Analyzing Policy Gaps in Optimal Pediatric HIV Treatment Regimens: A Global Overview Presenter: Amanda Banda | Breakout 2
Grand Caribbean S6-8 | |
| PrEP Implementation Strategies and Preferences Moderator: TBC 1018 Adolescent and Young Men and Women’s Divergent Preferences for Integrated PrEP Delivery Services: A Discrete Choice Experiment in Cape Town, South Africa Presenter: Elzette Rousseau 1165 High Interest for Long-acting Injectable PrEP among Pregnant Women Taking Daily Oral PrEP in Kisumu, Kenya Presenter: Tessa Concepcion 1174 A Qualitative Exploration of Sexually Transmitted Infection (STI) Partner Notification Preferences and Practices among Women Planning for Pregnancy and Considering HIV Pre-Exposure Prophylaxis in Durban, South Africa Presenter: Pooja Chitneni 1187 Who Starts — and Who Stays — on PrEP: An Analysis of Routine Facility Records in Lesotho Presenter: Lauren Greenberg 1252 An Economic Analysis of Factors Associated with Preexposure Prophylaxis Use for HIV Prevention in Women Presenter: Dion Allen | Breakout 3
Grand Caribbean Salon 5 | |
| 12:30 PM - 12:45 PM | Break | |
| 12:45 PM - 2:00 PM | SPONSORED LUNCH SYMPOSIUM
A Conversation with Puerto Rican Community Providers: Root Causes of Low PrEP Uptake on the Island Sponsored by IAPAC and Hosted by Latino Commission on AIDS Moderator: Gustavo Morales (Latino Commission on AIDS, New York, NY, USA) | General Session
Grand Caribbean Salon 4 |
| 2:00 PM - 2:15 PM | Break | |
| 2:15 PM - 3:15 PM | LATE-BREAKER ABSTRACTS | General Session
Grand Caribbean Salon 4 |
| 3:20 PM - 3:50 PM | HIGHLIGHTS FROM ADHERENCE 2023 | General Session
Grand Caribbean Salon 4 |
| Rapporteur Session | ||
| 3:50 PM - 4:00 PM | CLOSING REMARKS
Carmen Zorrilla (University of Puerto Rico, San Juan, PR) José M. Zuniga (IAPAC, Tampa, FL, USA) | General Session
Grand Caribbean Salon 4 |
| 4:00 PM | Adjourn |
Register
Venue and Accommodations
URGENT ANNOUNCEMENT: The Adherence 2023 venue hotel room block at the El Conquistador is SOLD OUT. Please refer to Expedia or some other online booking engine or travel agency to find available accommodations.
The Adherence 2023 conference venue will be El Conquistador, which is located at 1000 Avenida El Conquistador, Fajardo, 00738, Puerto Rico.
TRANSPORTATION
Shuttle transportation is available for a fee for travel between the San Juan International Airport (SJU) and El Conquistador – the Adherence 2023 venue and hotel. Please complete the relevant arrival or departure shuttle transportation form on this page to book your transportation. Note: transportation is organized by a third party and not by IAPAC. Any questions, concerns, or comments regarding shuttle transportation must be directed to the third party through the “Contact” tab on the booking website linked above.
Submit an Abstract
ABSTRACTS BOOKS
View the Adherence 2023 Poster Abstracts Schedule here.
View the Adherence 2023 Oral Abstracts Book here.
View the Adherence 2023 Poster Abstracts Book here.
If your abstract was accepted for either oral or poster presentation, and you confirmed your participation, then you will have received a guidance email.
View the Adherence 2023 oral abstracts FAQ here.
View the Adherence 2023 poster abstracts guidance and FAQ here.
Adherence 2023 will feature oral abstract and e-poster sessions. Below is guidance ahead of submitting your abstract(s) for the conference.
KEY DATES
Following are key dates relevant to abstract submissions:
- Abstract Submission Deadline – March 3, 2023
- Late-Breaker Abstract Submissions – March 27-31, 2023
- Abstract Disposition Announcements – April 7, 2023
- Late-Breaker Abstract Disposition Announcements – April 21, 2023
- Deadline to Withdraw Abstract/Change Presenting Author – May 5, 2023
CALL FOR ABSTRACTS
Abstract submissions are encouraged in a wide variety of specific domains, including:
- Antiretroviral therapy medication and medication adherence
- Linkage, retention, and re-engagement in HIV care
- Adherence and engagement in biomedical HIV prevention strategies
- Implementation science strategies
- Community engagement in planning, implementing, and monitoring HIV responses
Within these areas we encourage coverage of:
- Advances in basic science
- Innovative monitoring strategies
- Longitudinal or observational data
- Innovations in modeling and biopsychosocial theory
- Intervention development, implementation, and/or outcomes
- Dissemination/implementation of evidence-based approaches
- Operations research, demonstration projects, and practice-based approaches
- Health care policy and financing at local, state, and national levels
- Resource, structural, and service delivery issues and innovations
- Implementation science design, evidence, and real-world applicability
- Mitigation of HIV service disruption within the context of public health crises
Particularly as applied to key and disproportionately affected populations and settings:
- Treatment naïve, treatment experienced
- Individuals living with mental and/or physical health challenges
- Concomitant diseases (e.g., HBV, HCV, TB)
- Comorbid conditions (e.g., diabetes, hypertension)
- Syndemic conditions (e.g., mental health, substance use)
- Resource-constrained settings and geographies
- Key and vulnerable populations:
- Men who have sex with men (MSM)
- Transgender individuals
- Women in high HIV incidence areas
- Female and male sex workers
- Pregnant women
- Children and adolescents
- Substance users
- Incarcerated or recently released individuals
- Homeless and/or marginally housed individuals
ABSTRACT SUBMISSION
Abstracts must be submitted online by 5 pm ET, March 3, 2023. Submitted abstracts will be considered for oral or e-poster presentation. Submitted abstracts should report information not previously published, or intended to be published, prior to May 5, 2023.
It is the responsibility of the presenting author to ensure accuracy of content, spelling, and presentation. Abstracts will be published as submitted, subject to reformatting that may be required by IAPAC.
ABSTRACT FORMAT
Abstract contents will be either research-based data using established scientific methods or demonstrate experience and information from individuals or institutions working in the field. Please follow one of two structured formats (A or B), indicating in bold the four parts of your abstract:
Format A: Data-Driven Abstracts
- Background: a concise statement of the issues evaluated
- Methods: the investigational model used
- Results: specific findings
- Conclusions: summary of findings, supported by results
Format B: Program Descriptions and Case Studies
- Introduction: a concise statement of the issues addressed
- Description: a description of the project, case study, experience, or intervention
- Lessons Learned: project results, implementation issues, and/or case study solutions
- Recommendations: further recommendations or next steps
GENERAL GUIDELINES
Following are some general guidelines for individuals interested in submitting an abstract(s):
- The abstract must NOT contain more than 300 words.
- Acceptable abstracts shall contain a concise statement of the research, define the precise subject of the presentation, and be related to the main theme or a sub-theme of the conference.
- Literature references and acknowledgements should not form any part of the abstract’s content.
- Figures and tables are acceptable, subject to high definition/quality guidance to be provided.
- The author is responsible for grammatical and factual details, and may edit an abstract after it has been submitted up to May 5, 2023.
- All abstracts must be submitted in English (without exception).
- Sub-specialty jargon should be avoided, reflecting the interdisciplinary nature of the conference.
- Define all abbreviations and concepts in your abstract at first use.
- For therapeutic agents, only generic names may be used (trade names are not permitted).
ABSTRACT SUBMISSION AND ACCEPTANCE
All abstracts must be submitted online no later than 5:00 pm ET, March 3, 2023. Submissions will be acknowledged upon successful submission via the site. Faxed or mailed abstracts will not be considered.
Please record your abstract number. The number assigned to your abstract when it is submitted online will be the abstract number referenced throughout the conference, including in the Program and Abstracts book, during the Oral Abstract sessions, and during the e-Poster Session. A notice of acceptance or rejection will be sent via e-mail no later than April 7, 2023. A notice of acceptance or rejection for late-breaker submissions will be sent via e-mail no later than April 21, 2023. The disposition of each abstract will be sent via e-mail only to the submitting author identified on the submission form for that abstract. That contact will be responsible for sharing the disposition with all other authors of the abstract (including the presenting author).
Accepted abstracts will be in one of two categories:
1. Oral Abstract presentation
2. e-Poster Abstract presentation
Presenting authors agree to register for and attend the conference as scheduled in either Oral Abstract sessions or the e-Poster Session. Oral abstract and e-poster presenters are responsible for their own travel and accommodation expenses, as well as the applicable registration fees.
Note that only the abstracts of paid conference registrants will be included in the final Abstracts Book. Accepted abstracts will be published in the conference proceedings. Abstracts are considered official communication to IAPAC. Submission of an abstract implies permission to publish abstracts (including in the Journal of the International Association of Providers of AIDS Care [JIAPAC]) and online posting, if accepted. E-posters files must be transferred to IAPAC by June 2, 2023.
To reiterate, all abstract submissions must be received online by 5:00 pm ET, March 3, 2023. It is strongly recommended that you do not wait until the last minute to submit your abstract(s). You may review/edit submissions from now until 5:00 pm ET, May 5, 2023. Abstracts may be withdrawn or the presenter may be changed until May 5, 2023.
Call for Nominations
IAPAC “Rising Star” Award for an Early Career HIV Adherence Researcher
IAPAC would like to recognize an early career researcher (i.e., within 5 years of their terminal degree) who has begun to develop expertise in any aspect of HIV adherence research. The recipient will be chosen based on their potential to move the field forward in new and exciting directions.
IAPAC Outstanding Contribution to HIV Adherence Award for a Senior Researcher
IAPAC would like to recognize a senior researcher (i.e., more than 10 years after their terminal degree) who has defined or significantly advanced one or more areas of the adherence field. The recipient will be chosen based on their scientific impact, as well as mentorship of junior investigators.
Please nominate yourself or another by submitting the following information here by May 26, 2023:
- Biosketch (NIH format)
- One letter (max 1 page) describing the nominee’s impact on the field of HIV adherence research; more than one person may contribute to the letter
Recipients will be strongly encouraged to attend the conference in person.
Contact
Abstract and Registration-related queries:
Cassandra Moore, cmoore@iapac.org
Exhibitor, Satellite, and Sponsorship-related queries:
Jonathon Hess, jhess@iapac.org
Hotel-related queries:
John Charles, jcharles@ftcinstitute.org
